ANSELL (UNSP.ADRS)/4 (PD1) - Total Assets
Based on the latest financial reports, ANSELL (UNSP.ADRS)/4 (PD1) holds total assets worth €3.32 Billion EUR (≈ $3.88 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ANSELL (UNSP.ADRS)/4 - Total Assets Trend (2022–2025)
This chart illustrates how ANSELL (UNSP.ADRS)/4's total assets have evolved over time, based on quarterly financial data. Also see PD1 market cap overview for the company's overall valuation and market capitalisation.
ANSELL (UNSP.ADRS)/4 - Asset Composition Analysis
Current Asset Composition (June 2025)
ANSELL (UNSP.ADRS)/4's total assets of €3.32 Billion consist of 33.4% current assets and 66.6% non-current assets. Review total liabilities of ANSELL (UNSP.ADRS)/4 to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 7.2% |
| Accounts Receivable | €306.90 Million | 9.2% |
| Inventory | €584.70 Million | 17.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €320.20 Million | 9.6% |
| Goodwill | €1.34 Billion | 40.2% |
Asset Composition Trend (2022–2025)
This chart illustrates how ANSELL (UNSP.ADRS)/4's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See PD1 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ANSELL (UNSP.ADRS)/4's current assets represent 33.4% of total assets in 2025, a decrease from 39.3% in 2022.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, down from 8.2% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 41.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 40.2% of total assets.
ANSELL (UNSP.ADRS)/4 Competitors by Total Assets
Key competitors of ANSELL (UNSP.ADRS)/4 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
ANSELL (UNSP.ADRS)/4 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.13 | 3.84 | - |
| Quick Ratio | 1.01 | 2.75 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | €588.80 Million | €1.20 Billion | - |
ANSELL (UNSP.ADRS)/4 - Advanced Valuation Insights
This section examines the relationship between ANSELL (UNSP.ADRS)/4's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.24 |
| Latest Market Cap to Assets Ratio | 0.76 |
| Asset Growth Rate (YoY) | 2.5% |
| Total Assets | €3.32 Billion |
| Market Capitalization | $2.51 Billion USD |
Valuation Analysis
Below Book Valuation: The market values ANSELL (UNSP.ADRS)/4's assets below their book value (0.76x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: ANSELL (UNSP.ADRS)/4's assets grew by 2.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for ANSELL (UNSP.ADRS)/4 (2022–2025)
The table below shows the annual total assets of ANSELL (UNSP.ADRS)/4 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | €3.32 Billion ≈ $3.88 Billion |
+2.46% |
| 2024-06-30 | €3.24 Billion ≈ $3.79 Billion |
+28.14% |
| 2023-06-30 | €2.53 Billion ≈ $2.96 Billion |
+0.97% |
| 2022-06-30 | €2.51 Billion ≈ $2.93 Billion |
-- |
About ANSELL (UNSP.ADRS)/4
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves,… Read more